Geron Corp Files 8-K: Other Event Reported
Ticker: GERN · Form: 8-K · Filed: Jun 7, 2024 · CIK: 886744
| Field | Detail |
|---|---|
| Company | Geron Corp (GERN) |
| Form Type | 8-K |
| Filed Date | Jun 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory-filing
Related Tickers: GERN
TL;DR
GERN filed an 8-K for an 'Other Event' - details TBD.
AI Summary
On June 6, 2024, Geron Corporation (GERN) filed an 8-K to report an Other Event. The filing does not contain specific details about the event itself, but it was submitted on June 7, 2024, indicating a recent development for the company.
Why It Matters
This filing indicates a recent event or change at Geron Corporation that the company is legally obligated to disclose to the SEC, though the specific nature of the event is not detailed in this summary.
Risk Assessment
Risk Level: low — The filing is a standard disclosure of an 'Other Event' without immediate financial implications or significant new information provided.
Key Numbers
- 000-20859 — SEC File Number (Identifier for Geron Corp's SEC filings)
- 75-2287752 — IRS Employer Identification No. (Tax identification number for Geron Corp)
Key Players & Entities
- GERON CORP (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- 919 E. HILLSDALE BLVD., SUITE 250 (address) — Principal executive offices
- FOSTER CITY, CA (location) — City and State of principal executive offices
- June 6, 2024 (date) — Date of earliest event reported
- June 7, 2024 (date) — Filing date
FAQ
What specific event is Geron Corporation reporting under 'Other Events'?
The provided text of the 8-K filing does not specify the nature of the 'Other Event' being reported.
When was this 8-K filing submitted to the SEC?
The filing was submitted on June 7, 2024.
What is Geron Corporation's principal executive office address?
Geron Corporation's principal executive offices are located at 919 E. Hillsdale Blvd., Suite 250, Foster City, CA 94404.
What is Geron Corporation's state of incorporation?
Geron Corporation is incorporated in Delaware.
What is the earliest date of the event reported in this filing?
The earliest date of the event reported is June 6, 2024.
Filing Stats: 489 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-06-07 16:03:44
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value GERN The Nasdaq Stock Mar
Filing Documents
- gern-20240606.htm (8-K) — 43KB
- gern-ex99_1.htm (EX-99.1) — 47KB
- img50521483_0.jpg (GRAPHIC) — 3KB
- 0000950170-24-070574.txt ( ) — 217KB
- gern-20240606.xsd (EX-101.SCH) — 27KB
- gern-20240606_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events On June 6, 2024, Geron Corporation (the "Company") issued a press release announcing that the U.S. Food and Drug Administration ("FDA") has approved RYTELO TM (imetelstat) for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent (TD) anemia requiring four or more red blood cell units over eight weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA). A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated June 6, 2024 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GERON CORPORATION Date: June 7, 2024 By: /s/ Scott A. Samuels Name: Scott A. Samuels Title: Executive Vice President, Chief Legal Officer and Secretary